New Report Finds Consumer Knowledge Gap Constraining Concentrates Growth

Consumer Uncertainty Caps Category Potential

The survey of 2,400 U.S. adult-use consumers found that knowledge deficits—not product quality or price—represent the primary barrier to concentrates adoption. Released one week before the July 10 concentrates holiday, the report identifies a structural mismatch: while concentrates account for $3.2 billion in U.S. sales annually, nearly two-thirds of consumers report confusion over extraction methods, dosing protocols, and device compatibility.

European medical markets show similar patterns. Germany's BfArM registry shows concentrates represent just 8% of prescribed cannabis products, compared to 34% for dried flower, despite comparable therapeutic profiles. Canadian data from Health Canada's quarterly reports show similar hesitancy, with concentrates holding 18% market share four years post-legalization.

Extraction Method Opacity Drives Hesitation

Sixty-eight percent of respondents said they couldn't distinguish between solvent-based and solventless extraction processes, a gap that directly correlates with purchase reluctance. Consumers who understand the difference between butane hash oil (BHO), CO2 extraction, and rosin methods are 2.3 times more likely to purchase concentrates monthly.

This knowledge deficit creates retail friction. Budtenders in California and Colorado report spending 40% longer on concentrates transactions than flower sales, according to internal training data cited in the study. That time cost? It discourages repeat purchases in high-traffic dispensaries.

Device Compatibility Confusion Compounds Barrier

Fifty-four percent of surveyed consumers expressed uncertainty about which concentrate format pairs with which vaporization device. The proliferation of product types—shatter, wax, budder, live resin, rosin, diamonds, sauce—has outpaced consumer education infrastructure, the report concludes.

• Cartridge-based concentrates: 41% of respondents confident in use
• Dab rigs and e-nails: 19% confident
• Portable vaporizers: 28% confident
• Nectar collectors: 12% confident

Pre-filled cartridges—the most accessible format—drive the majority of concentrates volume. Higher-margin artisanal formats remain niche.

Dosing Precision Remains Opaque to Most Users

Seventy-one percent of respondents couldn't estimate appropriate serving sizes for concentrates, compared to 38% for flower and 22% for edibles. The report attributes this gap to inconsistent labeling standards and the absence of universal dosing guidance across state markets.

Israel's medical cannabis program mandates dosing calculators for all concentrate prescriptions, and patient surveys show 89% confidence in self-titration. The U.S. lacks comparable federal or multi-state harmonization, leaving education to individual retailers.

Retail Training Investment Lags Category Growth

Only 31% of dispensaries offer structured concentrates education programs for staff, despite the category's outsized margin contribution. Higher Function's analysis shows that dispensaries with formal training protocols see 47% higher concentrates sales per square foot than those relying on ad hoc knowledge transfer.

Newer markets show this gap more acutely. Ohio's adult-use rollout, which began in August 2024, shows concentrates at just 14% of sales—half the mature-market average—a lag researchers attribute to limited budtender fluency and consumer unfamiliarity.

7/10 Holiday Presents Education Opportunity

The July 10 concentrates holiday, observed by the industry since 2012, offers a concentrated window for consumer education campaigns. According to Lit's transaction data, concentrates sales spike 63% on 7/10 compared to an average July day, with first-time concentrate buyers accounting for 22% of transactions.

Retailers in Colorado, Washington, and Oregon have piloted in-store demonstrations, QR-linked video tutorials, and starter kits pairing concentrates with compatible devices. Early data from these initiatives show 34% higher repeat-purchase rates within 30 days.

What the Data Means for Market Expansion

If knowledge barriers were eliminated, the report projects U.S. concentrates sales could reach $5.8 billion by 2028, up from $3.2 billion in 2025. That growth would require coordinated industry investment in consumer education, standardized labeling, and retail training infrastructure.

The report's authors recommend that state regulators consider mandating product-education materials at point of sale, similar to requirements in Canada's Cannabis Act. Without intervention, the knowledge gap will continue to cap category potential, particularly as newer consumers enter legal markets.

For full context on concentrates market dynamics and extraction methods, see the CannIntel topic hub on the cannabis concentrates market.